Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

Ravindra Uppaluri, MD, PhD, discusses findings from the KEYNOTE-689 trial in adult patients with resectable, locally advanced head and neck squamous cell carcinoma.

A nurse was awarded an MBE in the 2025 King’s Birthday Honours because of her ‘truly inspiring’ work with patients.

"After my cancer diagnosis, I knew the initial assessment had missed everything. " Courtney Liniewski told Newsweek.

There are a number of things to look out for, but many of them often go ignored, according to leading oncologist Dr Jiri ...

Hamad Medical Corporation (HMC) hosted its inaugural Patient Awareness Programme, “Enhancing the Quality of Life of Patients ...

Step-and-shoot SPArc therapy reduces radiation to critical areas in head and neck tumours, showing promising results.

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

Leading oncologist Dr Jiri Kubes has shared some of the most common signs of head and neck cancer in a bid to raise awareness ...

A 56-year-old American man was diagnosed with stage 4 head and neck cancer after noticing a weird, painless boil on his ...

Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...

Keytruda marks the first perioperative anti-PD-1 treatment option for adults with PD-L1–positive resectable locally advanced ...